Moderna net income 2016-2023

Published by
Matej Mikulic,
Mar 1, 2024
This statistic illustrates the annual net loss of Moderna Inc. from 2016 to 2023. Moderna became well-known for developing one of the very first COVID-19 vaccines to be approved for widely usage in 2020. After the two very successful years 2021 and 2022, the company recorded a net loss of 4.7 billion U.S. dollars in 2023.

Moderna Inc.'s net income from 2016 to 2023 (in million U.S. dollars)

CharacteristicNet loss in million U.S. dollars
2023 -4,714
2022 8,362
2021 12,202
2020 -747
2019 -514
2018 -385
2017 -256
2016 -216
Showing entries 1 to 8 (8 entries in total)
Created with Highcharts 7.2.2Net loss in million U.S. dollars-216-216-256-256-385-385-514-514-747-74712,20212,2028,3628,362-4,714-4,71420162017201820192020202120222023

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Worldwide

Survey time period

2016 to 2023

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
mRNA technology
  • 38 page/s
  • English
  • pptx
  • Detailed references

Everything on "mRNA technology" in one document: edited and divided into chapters, including detailed references.

Go to report
Further reports
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on " Moderna Inc. "

Other statistics that may interest you Moderna Inc.

Market overview

6

Key figures

5

Competitors

4

Focus: COVID-19

8

Further related statistics

13

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.